ID

45282

Descrição

https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000001.v3.p1 The Age-Related Eye Disease Study (AREDS) was initially designed as a long-term multi-center, prospective study of the clinical course of age-related macular degeneration (AMD) and age-related cataract. In addition to collecting natural history data, AREDS included a clinical trial of high-dose vitamin and mineral supplements for AMD and a clinical trial of high-dose vitamin supplements for cataract. AREDS participants were 55 to 80 years of age at enrollment and had to be free of any illness or condition that would make long-term follow-up or compliance with study medications unlikely or difficult. On the basis of fundus photographs graded by a central reading center, best-corrected visual acuity and ophthalmologic evaluations, 4,757 participants were enrolled in one of several AMD categories, including persons with no AMD. The clinical trials for AMD and cataract were conducted concurrently. AREDS participants were followed on the clinical trials for a median time of 6.5 years. Subsequent to the conclusion of the clinical trials, participants were followed for an additional 5 years and natural history data were collected. The AREDS research design is detailed in AREDS Report 1. AREDS Report 8 contains the mainline results from the AMD trial; AREDS Report 9 contains the results of the cataract trial. Blood samples were also collected from 3,700+ AREDS participants for genetic research. Genetic samples from 600 AREDS participants (200 controls, 200 Neovascular AMD cases, and 200 Geographic Atrophy cases) were selected using data available in March 2005 and then were evaluated with a genome-wide scan. These data, as well as selected phenotypic data, were made available in the dbGaP. DNA from AREDS participants, which is currently being stored in the AREDS Genetic Repository, is available for research purposes. However, not all of the 3,700+ AREDS participants who submitted a blood sample currently have DNA available. In addition to including the data from the genome-wide scan on the 600 original samples, this second version of the AREDS dbGaP database provides a comprehensive set of data tables with extensive clinical information collected for the 4,757 participants who participated in AREDS. The tables include information collected at enrollment/baseline, during study follow-up, fundus and lens pathology, nutritional estimates, quality of life measures and measures of morbidity and mortality. In November 2010, over 72,000 high quality fundus and lens photographs from 595 AREDS participants (of the original 600 selected for the genome-wide scan) were made available in the AREDS dbGaP. In addition to the genome-wide scan data, the fundus and lens grading data for these participants are also available in the AREDS dbGaP. Details about the ocular photographs that are available are found here. In January 2012, a measure of daily sunlight exposure was added in a separate "sunlight" table. Furthermore, the "followup" table has been revised. The visual acuity for the right eye was inadvertently missing at odd-numbered visits (01, 03, 05, etc.). This data is now part of the table. It is hoped that this resource will better help researchers understand two important diseases that affect an aging population. These data may be applied to examination and inference on genetic and genetic-environmental bases for age-related diseases of public health significance and may also help elucidate the clinical course of both conditions, generate hypotheses, and aid in the design of clinical trials of preventive interventions. *Definitions of Final AMD Phenotype Categories* Please see phd001138.1 for a detailed description of how AREDS participants' final AMD phenotype was categorized. *User's Guide for AREDS Phenotype Data* A detailed User's Guide for the AREDS phenotype data is available. This *User's Guide* is meant to be a comprehensive document which explains the complexities of the AREDS data. *It is recommended that all researchers using AREDS phenotype data make use of this User's Guide*.

Link

dbGaP study = phs000001.v3.p1

Palavras-chave

  1. 11/05/2022 11/05/2022 - Martin Dugas
  2. 12/10/2022 12/10/2022 - Adrian Schulz
Titular dos direitos

Susan B. Bressler, MD, Wilmer Eye Institute, The Johns Hopkins Medical Institutions, Baltimore, MD

Transferido a

12 de outubro de 2022

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


Sem comentários

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

dgGaP phs000001.v3.p1 NEI Age-Related Eye Disease Study (AREDS)

The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.

  1. StudyEvent: SEV1
    1. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    2. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    3. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    9. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    10. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. Subject - Consent Information
    15. Subject - Sample Mapping (including mapping to Coriell IDs)
    16. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    17. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
pht000001.v2.p1
Descrição

pht000001.v2.p1

DUMMY ID NUMBER (EYE DISEASE RESEARCH ONLY PARTICIPANTS HAVE A DIFFERENT DUMMY ID NUMBER)
Descrição

ID2

Tipo de dados

string

NUMBER OF MATCHED GENETIC SPECIMENS FOR THE PARTICIPANT (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

MATCHSPEC

Tipo de dados

text

NUMBER OF UNTESTED GENETIC SPECIMENS FOR THIS PARTICIPANT (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

UNTESTSPEC

Tipo de dados

text

TOTAL NUMBER OF GENETIC SPECIMENS FOR THIS PARTICIPANT (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

TOTSPEC

Tipo de dados

text

AGE DOCTOR FIRST SAID HAD DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABAGE

Tipo de dados

text

YEARS TAKING INSULIN FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABINS

Tipo de dados

text

YEARS TAKING PILLS FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABPILL

Tipo de dados

text

YEARS CONTROLLING DIET FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABDIET

Tipo de dados

text

CURRENT DIABETES TREATMENT AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABTRT01

Tipo de dados

text

CURRENT DIABETES TREATMENT AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABTRT02

Tipo de dados

text

CURRENT DIABETES TREATMENT AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABTRT03

Tipo de dados

text

CURRENT DIABETES TREATMENT AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABTRT04

Tipo de dados

text

CURRENT DIABETES TREATMENT AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABTRT05

Tipo de dados

text

CURRENT DIABETES TREATMENT AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABTRT06

Tipo de dados

text

CURRENT DIABETES TREATMENT AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABTRT07

Tipo de dados

text

CURRENT DIABETES TREATMENT AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABTRT08

Tipo de dados

text

CURRENT DIABETES TREATMENT AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABTRT09

Tipo de dados

text

CURRENT DIABETES TREATMENT AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABTRT10

Tipo de dados

text

CURRENT DIABETES TREATMENT AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABTRT11

Tipo de dados

text

CURRENT DIABETES TREATMENT AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABTRT12

Tipo de dados

text

CURRENT DIABETES TREATMENT AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIABTRT13

Tipo de dados

text

AGE AT END OF CLINICAL TRIAL (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

AGECT

Tipo de dados

float

BASELINE NUCLEAR OPACITY SCORE: RIGHT EYE - RESCALED (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

RNUCBASE

Tipo de dados

float

BASELINE NUCLEAR OPACITY SCORE: LEFT EYE - RESCALED (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

LNUCBASE

Tipo de dados

float

FINAL PREDICTED NUCLEAR OPACITY SCORE: RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

RNUCSCORE

Tipo de dados

float

FINAL PREDICTED NUCLEAR OPACITY SCORE: LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

LNUCSCORE

Tipo de dados

float

BASELINE CORTICAL OPACITY PERCENTAGE FULL VISIBLE LENS - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

RCORBASE

Tipo de dados

float

BASELINE CORTICAL OPACITY PERCENTAGE FULL VISIBLE LENS - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

LCORBASE

Tipo de dados

float

FINAL PREDICTED CORTICAL OPACITY PERCENTAGE: FULL VISIBLE LENS - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

RCORSCORE

Tipo de dados

float

FINAL PREDICTED CORTICAL OPACITY PERCENTAGE: FULL VISIBLE LENS - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

LCORSCORE

Tipo de dados

float

BASELINE PSC OPACITY PERCENTAGE: CENTRAL 5 MM - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

RPSCBASE

Tipo de dados

float

BASELINE PSC OPACITY PERCENTAGE: CENTRAL 5 MM - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

LPSCBASE

Tipo de dados

float

FINAL PREDICTED PSC OPACITY PERCENTAGE: CENTRAL 5 MM - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

RPSCSCORE

Tipo de dados

float

FINAL PREDICTED PSC OPACITY: PERCENTAGE CENTRAL 5 MM - LEFT EYE (ALL PARTICIPANTS)
Descrição

LPSCSCORE

Tipo de dados

float

FINAL CATARACT PHENOTYPE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CATARACT

Tipo de dados

text

FINAL NUCLEAR OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

RNUC

Tipo de dados

text

FINAL NUCLEAR OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

LNUC

Tipo de dados

text

FINAL NUCLEAR OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

NUC

Tipo de dados

text

FINAL CORTICAL OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

RCOR

Tipo de dados

text

FINAL CORTICAL OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

LCOR

Tipo de dados

text

FINAL CORTICAL OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

COR

Tipo de dados

text

FINAL PSC OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

RPSC

Tipo de dados

text

FINAL PSC OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

LPSC

Tipo de dados

text

FINAL PSC OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

PSC

Tipo de dados

text

AGE AT RANDOMIZATION (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

ENROLLAGE

Tipo de dados

float

AGE AT LAST FUNDUS PHOTO (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

AGEPHOT

Tipo de dados

float

BASELINE PARTICIPANT AMD CATEGORY (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

AMDCAT

Tipo de dados

text

AREDS TREATMENT ASSIGNMENT (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

TRTCAT

Tipo de dados

text

MARITAL STATUS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

MARITAL

Tipo de dados

text

RACE OR ETHNIC BACKGROUND (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

RACE

Tipo de dados

text

SEX (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SEX

Tipo de dados

text

HIGHEST LEVEL OF SCHOOL ATTENDED (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SCHOOL

Tipo de dados

text

BODY-MASS INDEX AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

BMI00

Tipo de dados

float

BODY-MASS INDEX AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

BMI03

Tipo de dados

float

BODY-MASS INDEX AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

BMI04

Tipo de dados

float

BODY-MASS INDEX AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

BMI05

Tipo de dados

float

BODY-MASS INDEX AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

BMI06

Tipo de dados

float

BODY-MASS INDEX AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

BMI07

Tipo de dados

float

BODY-MASS INDEX AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

BMI08

Tipo de dados

float

BODY-MASS INDEX AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

BMI09

Tipo de dados

float

BODY-MASS INDEX AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

BMI10

Tipo de dados

float

BODY-MASS INDEX AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

BMI11

Tipo de dados

float

BODY-MASS INDEX AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

BMI12

Tipo de dados

float

BODY-MASS INDEX AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

BMI13

Tipo de dados

float

SMOKING STATUS AT BASELINE - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SMK00

Tipo de dados

text

SMOKING STATUS AT YEAR 3 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SMK03

Tipo de dados

text

SMOKING STATUS AT YEAR 4 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SMK04

Tipo de dados

text

SMOKING STATUS AT YEAR 5 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SMK05

Tipo de dados

text

SMOKING STATUS AT YEAR 6 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SMK06

Tipo de dados

text

SMOKING STATUS AT YEAR 7 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SMK07

Tipo de dados

text

SMOKING STATUS AT YEAR 8 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SMK08

Tipo de dados

text

SMOKING STATUS AT YEAR 9 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SMK09

Tipo de dados

text

SMOKING STATUS AT YEAR 10 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SMK10

Tipo de dados

text

SMOKING STATUS AT YEAR 11 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SMK11

Tipo de dados

text

SMOKING STATUS AT YEAR 12 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SMK12

Tipo de dados

text

SMOKING STATUS AT YEAR 13 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SMK13

Tipo de dados

text

SITTING SYSTOLIC BLOOD PRESSURE AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SYST00

Tipo de dados

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SYST03

Tipo de dados

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SYST04

Tipo de dados

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SYST05

Tipo de dados

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SYST06

Tipo de dados

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SYST07

Tipo de dados

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SYST08

Tipo de dados

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SYST09

Tipo de dados

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SYST10

Tipo de dados

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SYST11

Tipo de dados

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SYST12

Tipo de dados

text

SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

SYST13

Tipo de dados

text

SITTING DIASTOLIC BLOOD PRESSURE AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAS00

Tipo de dados

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAS03

Tipo de dados

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAS04

Tipo de dados

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAS05

Tipo de dados

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAS06

Tipo de dados

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAS07

Tipo de dados

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAS08

Tipo de dados

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAS09

Tipo de dados

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAS10

Tipo de dados

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAS11

Tipo de dados

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAS12

Tipo de dados

text

SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAS13

Tipo de dados

text

HISTORY OF DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB00

Tipo de dados

text

CURRENTLY HAVE DIABETES AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB01

Tipo de dados

text

CURRENTLY HAVE DIABETES AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB02

Tipo de dados

text

CURRENTLY HAVE DIABETES AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB03

Tipo de dados

text

CURRENTLY HAVE DIABETES AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB04

Tipo de dados

text

CURRENTLY HAVE DIABETES AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB05

Tipo de dados

text

CURRENTLY HAVE DIABETES AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB06

Tipo de dados

text

CURRENTLY HAVE DIABETES AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB07

Tipo de dados

text

CURRENTLY HAVE DIABETES AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB08

Tipo de dados

text

CURRENTLY HAVE DIABETES AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB09

Tipo de dados

text

CURRENTLY HAVE DIABETES AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB10

Tipo de dados

text

CURRENTLY HAVE DIABETES AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB11

Tipo de dados

text

CURRENTLY HAVE DIABETES AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB12

Tipo de dados

text

CURRENTLY HAVE DIABETES AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

DIAB13

Tipo de dados

text

HISTORY OF CANCER AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER00

Tipo de dados

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER01

Tipo de dados

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER02

Tipo de dados

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER03

Tipo de dados

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER04

Tipo de dados

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER05

Tipo de dados

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER06

Tipo de dados

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER07

Tipo de dados

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER08

Tipo de dados

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER09

Tipo de dados

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER10

Tipo de dados

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER11

Tipo de dados

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER12

Tipo de dados

text

NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CANCER13

Tipo de dados

text

HISTORY OF ANGINA AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

ANGINA00

Tipo de dados

text

HISTORY OF ANGINA AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

ANGINA03

Tipo de dados

text

HISTORY OF ANGINA AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

ANGINA04

Tipo de dados

text

HISTORY OF ANGINA AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

ANGINA05

Tipo de dados

text

HISTORY OF ANGINA AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

ANGINA06

Tipo de dados

text

HISTORY OF ANGINA AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

ANGINA07

Tipo de dados

text

HISTORY OF ANGINA AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

ANGINA08

Tipo de dados

text

HISTORY OF ANGINA AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

ANGINA09

Tipo de dados

text

HISTORY OF ANGINA AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

ANGINA10

Tipo de dados

text

HISTORY OF ANGINA AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

ANGINA11

Tipo de dados

text

HISTORY OF ANGINA AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

ANGINA12

Tipo de dados

text

HISTORY OF ANGINA AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

ANGINA13

Tipo de dados

text

TAKING CENTRUM DURING STUDY (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

CNTRMTAK

Tipo de dados

text

FINAL AMD PHENOTYPE (PARTICIPANTS WITH A GENETIC SPECIMEN)
Descrição

AMDSTAT

Tipo de dados

text

Similar models

The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.

  1. StudyEvent: SEV1
    1. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    2. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    3. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    9. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    10. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. Subject - Consent Information
    15. Subject - Sample Mapping (including mapping to Coriell IDs)
    16. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    17. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
pht000001.v2.p1
ID2
Item
DUMMY ID NUMBER (EYE DISEASE RESEARCH ONLY PARTICIPANTS HAVE A DIFFERENT DUMMY ID NUMBER)
string
MATCHSPEC
Item
NUMBER OF MATCHED GENETIC SPECIMENS FOR THE PARTICIPANT (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
UNTESTSPEC
Item
NUMBER OF UNTESTED GENETIC SPECIMENS FOR THIS PARTICIPANT (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
TOTSPEC
Item
TOTAL NUMBER OF GENETIC SPECIMENS FOR THIS PARTICIPANT (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIABAGE
Item
AGE DOCTOR FIRST SAID HAD DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Item
YEARS TAKING INSULIN FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
YEARS TAKING INSULIN FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never (0)
CL Item
Less than 5 years (1)
CL Item
More than or equal to 5 and less then 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS TAKING PILLS FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
YEARS TAKING PILLS FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never (0)
CL Item
Less than 5 years (1)
CL Item
More than or equal to 5 and less then 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
YEARS CONTROLLING DIET FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
YEARS CONTROLLING DIET FOR DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never (0)
CL Item
Less than 5 years (1)
CL Item
More than or equal to 5 and less then 10 years (2)
CL Item
More than or equal to 10 and less than 20 years (3)
CL Item
More than or equal to 20 years (4)
Item
CURRENT DIABETES TREATMENT AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENT DIABETES TREATMENT AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENT DIABETES TREATMENT AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENT DIABETES TREATMENT AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENT DIABETES TREATMENT AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENT DIABETES TREATMENT AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENT DIABETES TREATMENT AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENT DIABETES TREATMENT AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENT DIABETES TREATMENT AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENT DIABETES TREATMENT AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENT DIABETES TREATMENT AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENT DIABETES TREATMENT AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENT DIABETES TREATMENT AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
Item
CURRENT DIABETES TREATMENT AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENT DIABETES TREATMENT AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Diet treatment (D)
CL Item
Insulin treatment (I)
CL Item
Pill treatment (P)
AGECT
Item
AGE AT END OF CLINICAL TRIAL (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
RNUCBASE
Item
BASELINE NUCLEAR OPACITY SCORE: RIGHT EYE - RESCALED (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
LNUCBASE
Item
BASELINE NUCLEAR OPACITY SCORE: LEFT EYE - RESCALED (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
RNUCSCORE
Item
FINAL PREDICTED NUCLEAR OPACITY SCORE: RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
LNUCSCORE
Item
FINAL PREDICTED NUCLEAR OPACITY SCORE: LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
RCORBASE
Item
BASELINE CORTICAL OPACITY PERCENTAGE FULL VISIBLE LENS - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
LCORBASE
Item
BASELINE CORTICAL OPACITY PERCENTAGE FULL VISIBLE LENS - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
RCORSCORE
Item
FINAL PREDICTED CORTICAL OPACITY PERCENTAGE: FULL VISIBLE LENS - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
LCORSCORE
Item
FINAL PREDICTED CORTICAL OPACITY PERCENTAGE: FULL VISIBLE LENS - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
RPSCBASE
Item
BASELINE PSC OPACITY PERCENTAGE: CENTRAL 5 MM - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
LPSCBASE
Item
BASELINE PSC OPACITY PERCENTAGE: CENTRAL 5 MM - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
RPSCSCORE
Item
FINAL PREDICTED PSC OPACITY PERCENTAGE: CENTRAL 5 MM - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
LPSCSCORE
Item
FINAL PREDICTED PSC OPACITY: PERCENTAGE CENTRAL 5 MM - LEFT EYE (ALL PARTICIPANTS)
float
Item
FINAL CATARACT PHENOTYPE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
FINAL CATARACT PHENOTYPE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (1)
CL Item
Nuclear alone (2)
CL Item
Cortical alone (3)
CL Item
PSC alone (4)
CL Item
Nuclear/Cortical (5)
CL Item
Nuclear/PSC (6)
CL Item
Cortical/PSC (7)
CL Item
Nuclear/Cortical/PSC (8)
CL Item
Cataract Surgery/No specific type (9)
CL Item
Questionable (10)
Item
FINAL NUCLEAR OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
FINAL NUCLEAR OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (NUC-A)
CL Item
Present (NUC-B)
CL Item
Cataract Surgery (NUC-C)
CL Item
Questionable (NUC-D)
Item
FINAL NUCLEAR OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
FINAL NUCLEAR OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (NUC-A)
CL Item
Present (NUC-B)
CL Item
Cataract Surgery (NUC-C)
CL Item
Questionable (NUC-D)
Item
FINAL NUCLEAR OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
FINAL NUCLEAR OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (0)
CL Item
Present (1)
CL Item
Cataract Surgery (2)
CL Item
Questionable (3)
Item
FINAL CORTICAL OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
FINAL CORTICAL OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (COR-A)
CL Item
Present (COR-B)
CL Item
Cataract Surgery (COR-C)
CL Item
Questionable (COR-D)
Item
FINAL CORTICAL OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
FINAL CORTICAL OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (COR-A)
CL Item
Present (COR-B)
CL Item
Cataract Surgery (COR-C)
CL Item
Questionable (COR-D)
Item
FINAL CORTICAL OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
FINAL CORTICAL OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (0)
CL Item
Present (1)
CL Item
Cataract Surgery (2)
CL Item
Questionable (3)
Item
FINAL PSC OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
FINAL PSC OPACITY PHENOTYPE - RIGHT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (PSC-A)
CL Item
Present (PSC-B)
CL Item
Cataract Surgery (PSC-C)
CL Item
Questionable (PSC-D)
Item
FINAL PSC OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
FINAL PSC OPACITY PHENOTYPE - LEFT EYE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (PSC-A)
CL Item
Present (PSC-B)
CL Item
Cataract Surgery (PSC-C)
CL Item
Questionable (PSC-D)
Item
FINAL PSC OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
FINAL PSC OPACITY PHENOTYPE - PERSON (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Absent (0)
CL Item
Present (1)
CL Item
Cataract Surgery (2)
CL Item
Questionable (3)
ENROLLAGE
Item
AGE AT RANDOMIZATION (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
AGEPHOT
Item
AGE AT LAST FUNDUS PHOTO (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
Item
BASELINE PARTICIPANT AMD CATEGORY (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
BASELINE PARTICIPANT AMD CATEGORY (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
AMD Category 1 (1)
CL Item
AMD Category 2 (2)
CL Item
AMD Category 3a (3a)
CL Item
AMD Category 3b (3b)
CL Item
AMD Category 4a (4a)
CL Item
AMD Category 4b (4b)
Item
AREDS TREATMENT ASSIGNMENT (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
AREDS TREATMENT ASSIGNMENT (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Placebo (1)
CL Item
Antioxidants (2)
CL Item
Zinc (3)
CL Item
Antioxidants+Zinc (4)
Item
MARITAL STATUS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
MARITAL STATUS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Married (1)
CL Item
Divorced/separated (2)
CL Item
Widowed (3)
CL Item
Never married (4)
Item
RACE OR ETHNIC BACKGROUND (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
RACE OR ETHNIC BACKGROUND (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
White - not of Hispanic origin (1)
CL Item
Black - not of Hispanic origin (2)
CL Item
Hispanic (3)
CL Item
Asian or Pacific Islander (4)
CL Item
Other (5)
Item
SEX (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
SEX (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Female (F)
CL Item
Male (M)
Item
HIGHEST LEVEL OF SCHOOL ATTENDED (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HIGHEST LEVEL OF SCHOOL ATTENDED (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Grade 11 or less (1)
CL Item
High school graduate (2)
CL Item
Some college or associate degree (3)
CL Item
Bachelor's degree (4)
CL Item
Postgraduate work (5)
CL Item
Refused to answer (6)
BMI00
Item
BODY-MASS INDEX AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI03
Item
BODY-MASS INDEX AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI04
Item
BODY-MASS INDEX AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI05
Item
BODY-MASS INDEX AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI06
Item
BODY-MASS INDEX AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI07
Item
BODY-MASS INDEX AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI08
Item
BODY-MASS INDEX AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI09
Item
BODY-MASS INDEX AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI10
Item
BODY-MASS INDEX AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI11
Item
BODY-MASS INDEX AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI12
Item
BODY-MASS INDEX AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
BMI13
Item
BODY-MASS INDEX AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
float
Item
SMOKING STATUS AT BASELINE - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
SMOKING STATUS AT BASELINE - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 3 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
SMOKING STATUS AT YEAR 3 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 4 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
SMOKING STATUS AT YEAR 4 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 5 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
SMOKING STATUS AT YEAR 5 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 6 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
SMOKING STATUS AT YEAR 6 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 7 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
SMOKING STATUS AT YEAR 7 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 8 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
SMOKING STATUS AT YEAR 8 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 9 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
SMOKING STATUS AT YEAR 9 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 10 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
SMOKING STATUS AT YEAR 10 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 11 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
SMOKING STATUS AT YEAR 11 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 12 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
SMOKING STATUS AT YEAR 12 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
Item
SMOKING STATUS AT YEAR 13 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
SMOKING STATUS AT YEAR 13 - BASED ON HAVING SMOKED FOR 6 MONTHS (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Never smoked (1)
CL Item
Former Smoker (2)
CL Item
Current Smoker (3)
SYST00
Item
SITTING SYSTOLIC BLOOD PRESSURE AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST03
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST04
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST05
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST06
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST07
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST08
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST09
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST10
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST11
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST12
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
SYST13
Item
SITTING SYSTOLIC BLOOD PRESSURE AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS00
Item
SITTING DIASTOLIC BLOOD PRESSURE AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS03
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS04
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS05
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS06
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS07
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS08
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS09
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS10
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS11
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS12
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
DIAS13
Item
SITTING DIASTOLIC BLOOD PRESSURE AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Item
HISTORY OF DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF DIABETES AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENTLY HAVE DIABETES AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENTLY HAVE DIABETES AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENTLY HAVE DIABETES AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENTLY HAVE DIABETES AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENTLY HAVE DIABETES AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENTLY HAVE DIABETES AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENTLY HAVE DIABETES AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENTLY HAVE DIABETES AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENTLY HAVE DIABETES AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENTLY HAVE DIABETES AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENTLY HAVE DIABETES AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENTLY HAVE DIABETES AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
CURRENTLY HAVE DIABETES AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
CURRENTLY HAVE DIABETES AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF CANCER AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF CANCER AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 1 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 2 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
NEW DIAGNOSIS OF CANCER (SINCE LAST STUDY VISIT) AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF ANGINA AT BASELINE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF ANGINA AT YEAR 3 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF ANGINA AT YEAR 4 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF ANGINA AT YEAR 5 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF ANGINA AT YEAR 6 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF ANGINA AT YEAR 7 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF ANGINA AT YEAR 8 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF ANGINA AT YEAR 9 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF ANGINA AT YEAR 10 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF ANGINA AT YEAR 11 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF ANGINA AT YEAR 12 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
HISTORY OF ANGINA AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
HISTORY OF ANGINA AT YEAR 13 (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
TAKING CENTRUM DURING STUDY (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
TAKING CENTRUM DURING STUDY (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
No (N)
CL Item
Yes (Y)
Item
FINAL AMD PHENOTYPE (PARTICIPANTS WITH A GENETIC SPECIMEN)
text
Code List
FINAL AMD PHENOTYPE (PARTICIPANTS WITH A GENETIC SPECIMEN)
CL Item
Control (1)
CL Item
Control Questionable 1 (2)
CL Item
Control Questionable 2 (3)
CL Item
Control Questionable 3 (4)
CL Item
Control Questionable 4 (5)
CL Item
Large Drusen (6)
CL Item
Large Drusen Questionable 1 (7)
CL Item
Large Drusen Questionable 2 (8)
CL Item
Large Drusen Questionable 3 (9)
CL Item
Questionable AMD (10)
CL Item
NV AMD (11)
CL Item
GA (12)
CL Item
Both NV AMD and GA (13)
CL Item
Other non-control (14)

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial